GSK-1018921

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGSK-1018921
Drug Alias Name1018921GSK-1018921
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycine transporter 1 inhibitors
TargetsGlycine transporter 1
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanySpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A